Created at Source Raw Value Validated value
June 27, 2024, 4 p.m. usa

inclusion criteria: 1. adult patients, 18 years and above 2. confirmed sars-2-cov-2 infection by pcr 3. admitted to the hospital ward or the icu 4. subjects (or legally authorized representative) provides written informed consent prior to initiation of the study

inclusion criteria: 1. adult patients, 18 years and above 2. confirmed sars-2-cov-2 infection by pcr 3. admitted to the hospital ward or the icu 4. subjects (or legally authorized representative) provides written informed consent prior to initiation of the study

Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: adult patients, 18 years and above confirmed sars-2-cov-2 infection by pcr admitted to the hospital ward or the icu subjects (or legally authorized representative) provides written informed consent prior to initiation of the study

inclusion criteria: adult patients, 18 years and above confirmed sars-2-cov-2 infection by pcr admitted to the hospital ward or the icu subjects (or legally authorized representative) provides written informed consent prior to initiation of the study

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: 1. adult patients, 18 years and above 2. confirmed sars-2-cov-2 infection by pcr 3. admitted to the hospital ward or the icu 4. subjects (or legally authorized representative) provides written informed consent prior to initiation of the study

inclusion criteria: 1. adult patients, 18 years and above 2. confirmed sars-2-cov-2 infection by pcr 3. admitted to the hospital ward or the icu 4. subjects (or legally authorized representative) provides written informed consent prior to initiation of the study